Pharmaceutical

Werewolf Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

– Full enrollment in cutaneous melanoma dose-expansion arms of Phase 1/1b clinical trial evaluating WTX-124 as monotherapy and in combination with…

10 months ago

atai Life Sciences Announces First Patient Dosed in Elumina, the Phase 2 Clinical Trial of VLS-01 for Treatment-Resistant Depression

- Elumina is a Phase 2, multicenter, double-blind, randomized, placebo-controlled, clinical trial to assess the efficacy, safety and tolerability of…

10 months ago

Define Ventures Appoints Carolyn Magill as Venture Partner

The former Aetion and Remedy Partners CEO joins Define to further drive innovation across provider, payer, and pharmaceutical sectors SAN…

10 months ago

Azenta to Participate in the Virtual KeyBanc Capital Markets Healthcare Forum

BURLINGTON, Mass., March 10, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) announced that Lawrence Y. Lin, Executive Vice President and…

10 months ago

Clario Enters into Definitive Agreement to Acquire WCG’s eCOA Business

Acquisition of WCG's electronic clinical outcome assessments (eCOA) business will expand Clario's scientific expertise and offerings in neuroscience PHILADELPHIA, March 10,…

10 months ago

moveUP to Acquire Deep Structure.ai, Strengthening AI-Driven Orthopedic Care

NEW YORK, March 10, 2025 /PRNewswire/ -- moveUP.care, the Belgian and US-based leader in digital orthopedics, is proud to announce…

10 months ago

DarioHealth Reports Fourth Quarter and Full year 2024 Financial and Operating Results

Full-year 2024 revenue increased by 32.9% to $27.0 million from $20.4 million revenue in 2023.Revenue growth driven by B2B2C channel…

10 months ago

American Academy of Dermatology Awards Podium Presentation to Phio Pharmaceutical’s Clinical Research at 2025 Annual Meeting

Interim Results from clinical study for cutaneous carcinomas presented at Late-Breaking Research SessionMarlborough, Massachusetts--(Newsfile Corp. - March 10, 2025) -…

10 months ago

FAR Biotech joins JLABS

HOUSTON, March 10, 2025 /PRNewswire/ -- FAR Biotech, LLC ("FAR Biotech" or "FAR") is pleased to announce that it is now…

10 months ago

ACTG Presents Study at CROI Demonstrating Increased Risk of Obesity and Cardiometabolic Disease After Switch to Integrase Inhibitor-Containing Regimen

LOS ANGELES, March 08, 2025 (GLOBE NEWSWIRE) -- ACTG, a global clinical trials network focused on HIV and other infectious…

10 months ago